Characterization of Effects of G6PC2 Gene Variants on Transcription and Splicing

G6PC2 基因变体对转录和剪接的影响的表征

基本信息

  • 批准号:
    7713526
  • 负责人:
  • 金额:
    $ 38.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The glucose-6-phosphatase catalytic subunit gene family comprises three members, G6PC, G6PC2 and G6PC3. G6PC is predominantly expressed in liver where it catalyses the terminal step in the gluconeogenic and glycogenolytic pathways, namely the hydrolysis of glucose-6-phosphate (G6P) to glucose and inorganic phosphate. G6PC2, initially known as IGRP, is ~50% identical at the amino acid level to G6PC but it is expressed specifically in pancreatic islets. G6PC2 also hydrolyses G6P, though at a much lower rate than G6PC. This is consistent with the observation that deletion of the G6PC2 gene in mice results in decreased fasting blood glucose levels, suggesting that G6PC2 normally opposes the action of glucokinase in islets and lowers intracellular G6P concentrations and consequently glucose-stimulated insulin secretion. Two recent genome wide association (GWA) studies have linked single nucleotide polymorphisms (SNPs) in the G6PC2 gene to variations in fasting blood glucose levels in humans, a parameter that is linearly correlated with cardiovascular-associated mortality. Our preliminary data strongly support the hypothesis that sequence variations in the G6PC2 gene, rather than surrounding genes, contribute to elevated fasting blood glucose levels and hence cardiovascular-associated mortality. This project is therefore at a more advanced stage relative to many other GWA studies where disease-associated SNPs have been reported but the disease-associated genes remain to be identified. The goal of the experiments proposed in this application is to extend the GWA studies by functionally characterizing the effects of G6PC2 gene variants on transcription (Aim 1) and splicing (Aim 2). Our initial experiments have shown that two SNPs in the G6PC2 promoter affect G6PC2 fusion gene transcription. In addition, our sequence analyses suggest that the G6PC2 SNP that was first linked to variations in fasting blood glucose is located in a branch point, a key cis-acting element controlling pre-mRNA splicing.
描述(由申请人提供):葡萄糖-6-磷酸酶催化亚基基因家族包括三个成员,G6 PC、G6 PC 2和G6 PC 3。G6 PC主要在肝脏中表达,在肝脏中它催化糖原生成和糖原分解途径中的终末步骤,即葡萄糖-6-磷酸(G6 P)水解为葡萄糖和无机磷酸盐。 G6 PC 2,最初被称为IGRP,在氨基酸水平上与G6 PC约50%相同,但它在胰岛中特异性表达。G6 PC 2也水解G6 P,尽管速率比G6 PC低得多。这与小鼠中G6 PC 2基因缺失导致空腹血糖水平降低的观察结果一致,表明G6 PC 2通常对抗胰岛中葡萄糖激酶的作用并降低细胞内G6 P浓度,从而降低葡萄糖刺激的胰岛素分泌。 最近的两项全基因组关联(GWA)研究将G6 PC 2基因中的单核苷酸多态性(SNP)与人类空腹血糖水平的变化联系起来,这是一个与心血管相关死亡率线性相关的参数。我们的初步数据强烈支持这样的假设,即G6 PC 2基因的序列变异,而不是周围的基因,有助于空腹血糖水平升高,因此心血管相关的死亡率。 因此,相对于许多其他GWA研究,该项目处于更先进的阶段,其中已报告了疾病相关的SNP,但疾病相关的基因仍有待鉴定。本申请中提出的实验的目标是通过功能性表征G6 PC 2基因变体对转录(Aim 1)和剪接(Aim 2)的影响来扩展GWA研究。我们的初步实验表明,G6 PC 2启动子中的两个SNP影响G6 PC 2融合基因的转录。此外,我们的序列分析表明,G6 PC 2 SNP,这是第一次与空腹血糖的变化是位于一个分支点,一个关键的顺式作用元件控制前mRNA剪接。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard M O'Brien其他文献

Richard M O'Brien的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard M O'Brien', 18)}}的其他基金

G6PC Enzymology, Structure, Function and Role in the Regulation of Fasting Blood Glucose
G6PC 酶学、结构、功能及其在空腹血糖调节中的作用
  • 批准号:
    10584866
  • 财政年份:
    2023
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of Insulin Secretion by G6PC2
G6PC2 对胰岛素分泌的调节
  • 批准号:
    8323273
  • 财政年份:
    2011
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of Insulin Secretion by G6PC2
G6PC2 对胰岛素分泌的调节
  • 批准号:
    8663897
  • 财政年份:
    2011
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of Insulin Secretion by G6PC2
G6PC2 对胰岛素分泌的调节
  • 批准号:
    8461686
  • 财政年份:
    2011
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of Insulin Secretion by G6PC2
G6PC2 对胰岛素分泌的调节
  • 批准号:
    8161749
  • 财政年份:
    2011
  • 资助金额:
    $ 38.18万
  • 项目类别:
The Role of IGRP in the Pathogenesis of Type 1 Diabetes
IGRP 在 1 型糖尿病发病机制中的作用
  • 批准号:
    7998875
  • 财政年份:
    2010
  • 资助金额:
    $ 38.18万
  • 项目类别:
The Role of IGRP in the Pathogenesis of Type 1 Diabetes
IGRP 在 1 型糖尿病发病机制中的作用
  • 批准号:
    7138189
  • 财政年份:
    2006
  • 资助金额:
    $ 38.18万
  • 项目类别:
The Role of IGRP in the Pathogenesis of Type 1 Diabetes
IGRP 在 1 型糖尿病发病机制中的作用
  • 批准号:
    7280908
  • 财政年份:
    2006
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of IGRP Gene Expression
IGRP 基因表达的调控
  • 批准号:
    7053317
  • 财政年份:
    2003
  • 资助金额:
    $ 38.18万
  • 项目类别:
Regulation of IGRP Gene Expression
IGRP 基因表达的调控
  • 批准号:
    6875036
  • 财政年份:
    2003
  • 资助金额:
    $ 38.18万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 38.18万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 38.18万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 38.18万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 38.18万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 38.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了